DTaP-Hib vaccine

DTaP-Hib vaccine is a combination vaccine whose generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed with Haemophilus B conjugate vaccine, sometimes abbreviated to DTaP-Hib.^[2] It protects against the infectious diseases diphtheria, tetanus, pertussis, and Haemophilus influenzae type B.^[3][4]

DTaP-Hib vaccine

Combination of
DTaP vaccine	Vaccine
Hib vaccine	Vaccine
Clinical data
Trade names	TriHIBit[1]
Routes of administration	Intramuscular injection
ATC code	J07AG52 (WHO)
Identifiers
CAS Number	1670254-07-5

A branded formulation was marketed in the US as TriHIBit by Sanofi Pasteur, and administered by using the Sanofi DTaP vaccine Tripedia to reconstitute the Sanofi Hib vaccine ActHIB.^[3][5][6] TriHIBit and Tripedia were discontinued in 2011.^[7]

See also

• DPT vaccine